Explore the full management transaction log of ProNAi Therapeutics Inc, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was reported on 25 January 2016 (Levée d'options). Among the most active insiders: Rodigueza Wendi. All data is free.
10
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
7 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
ProNAi Therapeutics Inc is a biotechnology company focused on developing targeted therapies for cancer treatment. It utilizes a unique technology platform to design drugs based on oligonucleotides.